Back to top
more

Chemed (CHE)

(Real Time Quote from BATS)

$565.44 USD

565.44
19,913

+7.17 (1.28%)

Updated Nov 11, 2024 12:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks News

Tirthankar Chakraborty headshot

5 of the Best Efficient Stocks to Strengthen Your Portfolio

We have considered four popular ratios in order to find efficient companies that have the potential to provide impressive returns

    4 Growth Stocks to Pick From a Choppy MedTech Market

    In the wake of the volatile political scenario and taking a few favorable metrics into account, these MedTech stocks stand out as the most suitable picks.

      DaVita (DVA) Surges: Stock Moves 13.6% Higher

      DaVita (DVA) saw a big move last session, as its shares jumped nearly 14% on the day, amid huge volumes

        Chemed Banks on Roto-Rooter Sales, Focuses on Vitas Revival

        Chemed (CHE) continues to display robust performance in Roto-Rooter business on strength in core plumbing and drain cleaning service segments.

          Align Technology Rides High on InvisAlign & Strategic Pacts

          Rising demand for InvisAlign products in the global teen market and the distribution agreement with Patterson Dental are major upsides for Align (ALGN).

            Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources

            Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources

              Tirthankar Chakraborty headshot

              5 of the Most Efficient Stocks to Boost Your Portfolio

              Company with a favorable efficiency level generally provides impressive returns as it is believed to be positively correlated with the stock's price performance.

                Envision Healthcare Down More Than 50% This Year, Here's Why

                Envision Healthcare (EVHC) seems to be bogged down by soft patient volumes, increasing expenses and high leverage.

                  Chemed (CHE) Up 13.6% Since Earnings Report: Can It Continue?

                  Chemed (CHE) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                    Envision Healthcare Hits 52-Week Low on Q3 Miss, Grim View (Revised)

                    Envision Healthcare (EVHC) stock suffers on soft third-quarter results and a tepid outlook.

                      Envision Healthcare Hits 52-Week Low on Q3 Loss, Grim View

                      Envision Healthcare (EVHC) stock suffers on soft third-quarter results and a tepid outlook.

                        Envision Healthcare Continues to Expand Physician Services

                        Envision Healthcare's (EVHC) numerous acquisitions and management changes are aimed at growing its physician services segment.

                          STERIS (STE) Rides on Organic Growth, Stiff Contest a Threat

                          STERIS' (STE) consistent strong organic all-segment growth performance impresses investors. Additionally, growth in free cash flow reserve denotes the company's solid cash position.

                            AmerisourceBergen's PharMEDium Slows Down, Competition Rife

                            AmerisourceBergen Corporation's (ABC) expects tepid performance from PharMEDium due to pricing pressure in the generic drug space.

                              CVS Health Gains on Pharmacy Services, Retail Remains a Drag

                              CVS Health (CVS) benefits from strong Pharmacy Services numbers and continues to deliver solid PBM selling seasons. Retail performance stays sluggish on several headwinds.

                                Brian Bolan headshot

                                Omnova Solutions and Chemed are Zacks Aggressive Growth Rank Buys

                                OMN and CHE are profiled as aggressive growth stocks.

                                  Why Is Chemed (CHE) Down 7.8% Since the Last Earnings Report?

                                  Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                    Here's Why You Must Add Chemed (CHE) Stock to Your Portfolio

                                    Chemed Corporation's (CHE) promising Roto-Rooter revenue outlook as well as an increased bottom-line guidance bode well of the company's future.

                                      Zacks.com featured highlights: Arkema SA, Nutrisystem, Braskem SA, Chemed and SP Plus

                                      Zacks.com featured highlights: Arkema SA, Nutrisystem, Braskem SA, Chemed and SP Plus

                                        5 Top Stocks With Solid Net Profit Margin

                                        Net profit is the amount a company retains after deducting all costs, interest, depreciation, taxes and other expenses.

                                          Envision Healthcare Hurt by High Debt, Increasing Expenses

                                          Envision Healthcare's (EVHC) increasing debt and expenses continue to hurt. Further guidance cut by the company is concerning.

                                            Zacks.com featured highlights: Arkema, Nutrisystem, SYNNEX, Ituran Location and Control and Chemed

                                            Zacks.com featured highlights: Arkema, Nutrisystem, SYNNEX, Ituran Location and Control and Chemed

                                              5 Top Stocks with Stellar Net Profit Margin

                                              Net profit is the amount a company retains after deducting all costs, interest, depreciation, taxes and other expenses.

                                                Chemed (CHE) Q2 Earnings & Revenues Rise Y/Y, View Revised

                                                Chemed (CHE) rides high on Roto-Rooter in second-quarter 2017. An encouraging bottom-line projection raises hopes.

                                                  Chemed (CHE) Up 6.4% Since Earnings Report: Can It Continue?

                                                  Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.